AMY-101
AMY-101 is a potent peptidic inhibitor targeting the central complement protein C3 with sub-nanomolar affinity. It has demonstrated promising anti-inflammatory efficacy in preclinical models of severe COVID-19 pneumonia characterized by systemic hyperinflammation, supporting its research use in complement-driven inflammatory diseases.
Product Specifications
Field of Research
Immunology & Inflammation, Infectious Disease & Virology
Molecular Weight
1789.11
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
17256121 3x 1.0µg DNA
CYCSP16 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details